Sheela Foam Ltd

Sheela Foam Ltd

₹ 626 -0.63%
29 May 10:46 a.m.
About

Sheela Foam Limited is a leading player in India’s mattress and foam products industry and a leader in Polyurethane (PU) Foam. It has a nationwide presence in manufacturing PU Foam with a track record, since 1971. [1]

Key Points

Largest Manufacturer of Polyurethane Foam
The company is India's largest manufacturer of flexible slab stock Polyutherane (PU) foam and mattresses under Sleepwell, Furlenco, and Kurlon [1] with a 30% market share in India’s mattress segment and a 40% market share in Australia. The Kurlon brand holds a 12-13% market share of the modern mattress market.[2] [3] [4]

  • Market Cap 6,802 Cr.
  • Current Price 626
  • High / Low 1,067 / 618
  • Stock P/E 65.5
  • Book Value 257
  • Dividend Yield 0.00 %
  • ROCE 6.19 %
  • ROE 3.80 %
  • Face Value 5.00

Pros

  • Company is expected to give good quarter

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 8.73% over past five years.
  • Company has a low return on equity of 6.39% over last 3 years.
  • Earnings include an other income of Rs.95.0 Cr.
  • Promoter holding has decreased over last 3 years: -7.26%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
537 488 533 515 519 456 423 513 487 504 602 791 691
482 443 470 463 461 395 377 460 437 456 532 720 645
Operating Profit 55 45 63 52 58 61 46 53 50 48 71 71 46
OPM % 10% 9% 12% 10% 11% 13% 11% 10% 10% 9% 12% 9% 7%
15 16 20 24 18 11 22 22 59 37 29 9 20
Interest 1 2 2 1 2 2 3 18 20 22 22 23 28
Depreciation 9 7 8 8 12 11 13 15 20 19 22 23 24
Profit before tax 61 52 73 67 62 59 52 42 69 44 56 34 13
Tax % 22% 26% 28% 21% 32% 27% 26% 27% 18% 27% 23% 27% 7%
47 38 52 53 42 43 38 31 56 32 43 25 12
EPS in Rs 4.85 3.92 5.33 5.40 4.28 4.38 3.52 2.84 5.18 2.95 3.95 2.29 1.12
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
953 1,077 1,265 1,376 1,580 1,738 1,703 1,694 2,008 2,039 1,880 2,588
897 1,013 1,124 1,213 1,387 1,555 1,478 1,457 1,774 1,830 1,669 2,352
Operating Profit 56 64 141 162 193 184 224 237 234 208 210 235
OPM % 6% 6% 11% 12% 12% 11% 13% 14% 12% 10% 11% 9%
8 13 21 26 23 30 32 47 70 75 114 95
Interest 12 10 7 7 6 7 8 9 7 8 44 94
Depreciation 20 22 23 24 28 31 33 33 32 41 58 89
Profit before tax 32 46 132 157 182 176 215 243 265 234 222 147
Tax % 21% 24% 32% 29% 31% 30% 23% 26% 25% 27% 24% 24%
25 34 90 111 126 124 166 181 197 171 168 112
EPS in Rs 7.70 10.60 27.74 11.39 12.90 12.67 16.96 18.56 20.22 17.54 15.48 10.31
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 9%
5 Years: 9%
3 Years: 9%
TTM: 38%
Compounded Profit Growth
10 Years: 11%
5 Years: -8%
3 Years: -18%
TTM: -17%
Stock Price CAGR
10 Years: %
5 Years: -2%
3 Years: -24%
1 Year: -30%
Return on Equity
10 Years: 13%
5 Years: 9%
3 Years: 6%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 16 16 16 24 24 24 24 24 24 49 54 54
Reserves 170 204 294 397 522 645 806 989 1,185 1,313 2,620 2,739
91 72 46 4 1 0 3 2 19 149 1,000 949
193 248 288 350 341 353 337 406 379 406 521 647
Total Liabilities 471 540 645 775 888 1,023 1,170 1,421 1,608 1,917 4,196 4,390
165 190 201 233 254 269 279 278 257 311 504 561
CWIP 17 8 2 3 4 1 17 1 1 103 80 39
Investments 23 30 53 73 195 416 443 623 839 960 3,068 3,112
266 311 390 466 436 337 431 519 511 543 543 677
Total Assets 471 540 645 775 888 1,023 1,170 1,421 1,608 1,917 4,196 4,390

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
121 110 171 102 114 120 130 178 196 147 246 228
-26 -41 -41 4 -71 -240 -103 -163 -210 -186 -2,160 -53
-54 -31 -32 -50 -9 -8 -9 -9 -6 38 1,915 -165
Net Cash Flow 40 39 97 56 34 -129 18 6 -21 -2 -0 10

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 31 27 21 26 23 22 27 35 25 25 37 34
Inventory Days 51 48 41 52 53 57 73 93 55 63 51 43
Days Payable 52 57 49 63 46 43 50 95 53 57 55 49
Cash Conversion Cycle 30 17 13 15 30 35 50 33 27 30 33 28
Working Capital Days 12 -12 -20 -10 4 9 20 19 14 7 -15 56
ROCE % 16% 20% 42% 42% 39% 29% 29% 25% 23% 16% 8% 6%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
72.95% 72.95% 72.95% 72.95% 72.95% 65.48% 65.48% 65.48% 65.48% 65.48% 65.69% 65.69%
3.11% 3.16% 3.19% 3.26% 3.21% 6.04% 6.12% 6.32% 6.40% 6.60% 6.56% 6.23%
22.84% 22.73% 22.43% 22.28% 21.95% 25.08% 24.99% 24.52% 23.40% 22.30% 21.03% 21.17%
1.10% 1.14% 1.43% 1.50% 1.89% 3.40% 3.40% 3.68% 4.72% 5.62% 6.71% 6.91%
No. of Shareholders 18,23118,94525,29127,23230,57444,13739,44439,10351,04755,95460,35460,089

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls